These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation. Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641 [TBL] [Abstract][Full Text] [Related]
6. The DOSE study: a clinical trial to examine efficacy and dose response of exercise as treatment for depression. Dunn AL; Trivedi MH; Kampert JB; Clark CG; Chambliss HO Control Clin Trials; 2002 Oct; 23(5):584-603. PubMed ID: 12392873 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder. Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552 [TBL] [Abstract][Full Text] [Related]
8. Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials. Soares CN; Kornstein SG; Thase ME; Jiang Q; Guico-Pabia CJ J Clin Psychiatry; 2009 Oct; 70(10):1365-71. PubMed ID: 19906341 [TBL] [Abstract][Full Text] [Related]
9. Randomized trial of the efficacy of bright-light exposure and aerobic exercise on depressive symptoms and serum lipids. Leppämäki SJ; Partonen TT; Hurme J; Haukka JK; Lönnqvist JK J Clin Psychiatry; 2002 Apr; 63(4):316-21. PubMed ID: 12000205 [TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder. Colonna L; Andersen HF; Reines EH Curr Med Res Opin; 2005 Oct; 21(10):1659-68. PubMed ID: 16238906 [TBL] [Abstract][Full Text] [Related]
11. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Kivitz A; Ma C; Ahdieh H; Galer BS Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450 [TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury. Ashman TA; Cantor JB; Gordon WA; Spielman L; Flanagan S; Ginsberg A; Engmann C; Egan M; Ambrose F; Greenwald B Arch Phys Med Rehabil; 2009 May; 90(5):733-40. PubMed ID: 19406291 [TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074 [TBL] [Abstract][Full Text] [Related]
15. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder. Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749 [TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292 [TBL] [Abstract][Full Text] [Related]
17. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder. Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792 [TBL] [Abstract][Full Text] [Related]
19. Effects of exercise programs on falls and mobility in frail and pre-frail older adults: A multicenter randomized controlled trial. Faber MJ; Bosscher RJ; Chin A Paw MJ; van Wieringen PC Arch Phys Med Rehabil; 2006 Jul; 87(7):885-96. PubMed ID: 16813773 [TBL] [Abstract][Full Text] [Related]
20. An open-label, flexible-dose study of memantine in major depressive disorder. Ferguson JM; Shingleton RN Clin Neuropharmacol; 2007; 30(3):136-44. PubMed ID: 17545748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]